Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/606,769external-prioritypatent/US5130430A/en
Application filed by Neurogen CorpfiledCriticalNeurogen Corp
Publication of MY107732ApublicationCriticalpatent/MY107732A/en
THIS INVENTION ENCOMPASSES COMPOUNDS OF THE FORMULA: (FORMULA 1) AND THE PHARMACEUTICALLY ACCEPTABLE NON- TOXIC SALTS THEREOF WHEREIN R1, R2, R3, R4, X, AND W ARE VARIABLES. THESE COMPOUNDS ARE HIGHLY SELECTIVE AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GABAA BRAIN RECEPTORS OR PRODRUGS THEREOF AND ARE USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP, AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND ENHANCEMENT OF MEMORY.
MYPI92000564A1990-10-311992-04-01Certain imidazoquinoxalines; a new class of gaba brain receptor ligands.
MY107732A
(en)